Share this page:
Fact Sheet for Health Care Providers: Emergency Use Authorization (EUA) of BARICITINIB
EUA: For emergency use by healthcare providers for the treatment of suspected or laboratory-confirmed COVID-19 in hospitalized adults and pediatric patients 2 years of age or older requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).
Date Last Updated (Year-Month-Day)
Download Heathcare Providers Fact Sheet directly: https://www.fda.gov/media/143823/download
Download Patients, Parents, and Caregivers Fact Sheet directly: https://www.fda.gov/media/143824/download